Cephalon sales rise, but fall short of estimates; RoActemra wins new use in Europe;

@FiercePharma: Wockhardt finally unloads nutrition unit to Danone. French giant also said to be eyeing Pfizer's nutrition biz. Story | Follow @FiercePharma

> Cephalon sales lagged analyst estimates while costs rose as revenues from its narcolepsy drug Provigil dropped by 5%. More

> Roche's RoActemra won European approval for use in children with Systemic Juvenile Idiopathic Arthritis, a rare and serious form of the disease. Story

> Pfizer's Sutent is prescribed by virtually all U.S. doctors treating kidney cancer, with Bayer's Nexavar used by 89%. Release

> Regulators pronounced success with a joint inspection pilot program uniting the FDA, the European Medicines Agency, and regulators in Australia, France, Germany, Ireland and more. Report

> Impax Laboratories profits sank by 60% as it lost exclusivity in the market for generic Flomax, a prostate drug. Piece

> Generics maker Akorn posted a $17.9 million Q2 profit and agreed to buy a stake in eye drug specialist Aciex Therapeutics. Item

> Agvar Chemicals founder Agnes Varis, a leading figure in the generics industry and access-to-generics advocate, has died at 81. News

Biotech News

@FierceBiotech: Insmed shares crater as FDA puts a clamp on Ph3 CF study. Report | Follow @FierceBiotech

@JohnCFierce: Sometimes wonder when/if a Big Pharma would do a Valeant, punt early-stage research, pick up good stuff after PoC. Pfizer? | Follow @JohnCFierce

@RyanMFierce: BioClinica 2Q earnings out, service revenue up 8.7% News $BIOC | Follow @RyanMFierce

@MaureenFierce: Which 3 Pharmas are tops for cardiology meds? $PFE is one, according to doctors. Article #sermosurveys | Follow @MaureenFierce

> AMAG investor out to derail Allos merger with buyout offer. More

> Vectura gains mystery partner for VR315 lung drug. Article

> SEC lays out "tall tales" in $20M biotech securities scam. Report

> Merck scores promising pivotal data on allergy treatment. News

> A drug development revolutionary advocates radical change in R&D. Story

> Celgene tackles anemia in $242M development pact with Acceleron. More

Drug Delivery News

> More companies going with prefilled syringes ahead of flu season. Item

> Growth factor delivery method makes long-lasting blood vessels. More

> Pfizer completes sale of Capsugel delivery unit. Report

> OctoPlus tries to get drug-delivery tentacles into generics. Story

> Nanomaterial improves on VEGF for blood-vessel growth. News

> Depomed inks another deal for AcuForm, this time with Ironwood. Article

Medical Device News

> FMD speaks with Cell>Point's David Rollo. Item

> Berlin Heart pediatric offering could soon help U.S. patents. Piece

> Restoration Robotics raises $41M. Story

> BD, Lab21 team on Aspergillus assay. News

> Fresenius buys U.S. competitors. Article

> Ellipse Technologies completes $17.6M Series C financing. More

> Becton Dickson sees strong Q3. Report

And Finally... Dark chocolate plus exercise equals healthier muscles, mouse study finds. Report